Published April 10, 2026 | Version 2

In Silico Hit-to-Lead Discovery Against Plasmodium falciparum Dihydroorotate Dehydrogenase via Geometric Docking: A Novel Fluoroalkylpyrazine Scaffold with Blood-Brain Barrier Permeability

Description

Abstract:

Malaria, caused by Plasmodium falciparum, kills over 600,000 people annually. Cerebral malaria—the most lethal complication—remains particularly difficult to treat because most available agents fail to cross the blood-brain barrier (BBB). Dihydroorotate dehydrogenase (PfDHODH) is a validated antimalarial target with clinical precedent; however, resistance to first-generation inhibitors motivates the search for structurally novel scaffolds. We applied a geometric docking engine to the PfDHODH active site (PDB 3I65) and identified a novel fluoroalkylpyrazine scaffold (FCCc1cnccn1) as a Stage 1 hit candidate. The compound achieves a docking score of 171.0, predicts high gastrointestinal absorption and BBB permeability, and violates zero Lipinski rules. Crucially, the scaffold lacks prior pharmacological record in global databases, establishing a new chemical entity (NCE) for central nervous system-penetrant antimalarial development.

Files

pirolo2026_malaria-2.pdf

Files (735.0 kB)

Name Size
md5:d47540b6a16a30919979d96068d4f53a
309.6 kB Preview Download
md5:055319587bb6f065a7f3ffce2543edd8
425.3 kB Preview Download

Additional details

Software

Programming language
C++